159 related articles for article (PubMed ID: 24002537)
1. MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?
Sautter-Bihl ML; Hohenberger W; Fietkau R; Roedel C; Schmidberger H; Sauer R
Ann Surg Oncol; 2014 Jan; 21(1):197-204. PubMed ID: 24002537
[TBL] [Abstract][Full Text] [Related]
2. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study.
Strassburg J; Ruppert R; Ptok H; Maurer C; Junginger T; Merkel S; Hermanek P
Ann Surg Oncol; 2011 Oct; 18(10):2790-9. PubMed ID: 21509631
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
4. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
Wieder HA; Rosenberg R; Lordick F; Geinitz H; Beer A; Becker K; Woertler K; Dobritz M; Siewert JR; Rummeny EJ; Stollfuss JC
Radiology; 2007 Jun; 243(3):744-51. PubMed ID: 17463134
[TBL] [Abstract][Full Text] [Related]
5. Resectable rectal cancer: which patient does not need preoperative radiotherapy?
Kulu Y; Ulrich A; Büchler MW
Dig Dis; 2012; 30 Suppl 2():118-25. PubMed ID: 23207943
[TBL] [Abstract][Full Text] [Related]
6. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge.
Engelen SM; Maas M; Lahaye MJ; Leijtens JW; van Berlo CL; Jansen RL; Breukink SO; Dejong CH; van de Velde CJ; Beets-Tan RG; Beets GL
Eur J Cancer; 2013 Jul; 49(10):2311-20. PubMed ID: 23571146
[TBL] [Abstract][Full Text] [Related]
7. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
[TBL] [Abstract][Full Text] [Related]
9. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer.
Martling A; Holm T; Bremmer S; Lindholm J; Cedermark B; Blomqvist L
Br J Surg; 2003 Nov; 90(11):1422-8. PubMed ID: 14598425
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
12. Rectal cancer: review with emphasis on MR imaging.
Beets-Tan RG; Beets GL
Radiology; 2004 Aug; 232(2):335-46. PubMed ID: 15286305
[TBL] [Abstract][Full Text] [Related]
13. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
14. Management and imaging of low rectal carcinoma.
Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
[TBL] [Abstract][Full Text] [Related]
15. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
Taylor FG; Quirke P; Heald RJ; Moran BJ; Blomqvist L; Swift IR; Sebag-Montefiore D; Tekkis P; Brown G;
J Clin Oncol; 2014 Jan; 32(1):34-43. PubMed ID: 24276776
[TBL] [Abstract][Full Text] [Related]
16. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
17. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer].
Rödel C; Sauer R; Fietkau R
Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930
[TBL] [Abstract][Full Text] [Related]
18. Oncological short-term effects and adverse events of MRI-guided selective neoadjuvant radiochemotherapy for rectal cancer.
Maurer CA; Mattiello D; Duwe J; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
Anticancer Res; 2012 May; 32(5):1721-8. PubMed ID: 22593452
[TBL] [Abstract][Full Text] [Related]
19. Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study.
Frasson M; Garcia-Granero E; Parajó A; Garcia-Mayor L; Flor B; Garcia-Granero A; Lavery I
Colorectal Dis; 2015 Aug; 17(8):689-97. PubMed ID: 25735444
[TBL] [Abstract][Full Text] [Related]
20. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.
Kusters M; Marijnen CA; van de Velde CJ; Rutten HJ; Lahaye MJ; Kim JH; Beets-Tan RG; Beets GL
Eur J Surg Oncol; 2010 May; 36(5):470-6. PubMed ID: 20096534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
